AstraZeneca PLC (AZN)

Add to research

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance
Add to research

Current Price

as of Feb 13, 2025

$149.26

P/E Ratio

33.68

Market Cap

$231.44B

Description
Add to research

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

Metrics
Add to research

Overview

  • HQCambridge, CA
  • SectorHealth Technology
  • IndustryPharmaceuticals: Major
  • TickerAZN
  • Price$149.257083+1.64%

Trading Information

  • Market cap$231.44B
  • Float94.77%
  • Average Daily Volume (1m)1,396,829
  • Average Daily Volume (3m)1,418,792
  • EPS$3.55

Company

  • Revenue$42.32B
  • Rev growth (1yr)14.82%
  • Net income$5.51B
  • Gross margin72.23%
  • EBITDA margin32.54%
  • EBITDA$13.77B
  • EV$183.36B
  • EV/Revenue4.33
  • P/E33.68
  • P/S4.42
  • P/B6.11
  • Debt/Equity74.28
Documents
Add to research
Factset Street Account